See every side of every news story
Published loading...Updated

Gilead Sciences Q2 EPS Forecast Increased by Zacks Research

Summary by Com-unik.info
Gilead Sciences, Inc. (NASDAQ:GILD – Free Report) – Investment analysts at Zacks Research lifted their Q2 2025 earnings per share estimates for Gilead Sciences in a research note issued to investors on Thursday, January 16th. Zacks Research analyst E. Bagri now anticipates that the biopharmaceutical company will earn $1.75 per share for the quarter, up […]
DisclaimerThis story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.

2 Articles

All
Left
Center
Right
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

com-unik.info broke the news in on Wednesday, January 22, 2025.
Sources are mostly out of (0)